Skip to content

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Evaluation of the LithoVue Elite Ureteroscope With Intra-Renal Pressure Monitoring Technology: Examination of Surgeon Behavior and Post-operative Outcomes

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06576661
Acronym
ELITE
Enrollment
80
Registered
2024-08-29
Start date
2025-01-28
Completion date
2026-11-01
Last updated
2026-05-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stone, Nephrolithiasis

Keywords

Intrarenal Pressure, LithoVue Elite

Brief summary

The goal of this study is to evaluate the influence of real-time intrarenal pressure measurement availability on surgeons' behavior during ureteroscopy while using the ureteroscope LithoVue Elite.

Detailed description

Despite advances in surgical techniques and technology, preventable adverse events still occur in the operating room, with half of them attributed to poor non-technical skills of surgical teams. Therefore, it is essential to observe and measure surgeons' intraoperative non-technical skills and provide structured feedback to improve patient safety. The new LithoVue Elite™ disposable ureteroscope has the potential to impact surgeons' behavior during ureteroscopy, as it enables the measurement of real-time intrarenal pressures. The study is designed to evaluate urologists' behavior during ureteroscopic stone treatment with and without intra-renal pressure monitoring.

Interventions

DEVICEINTRARENAL PRESSURE MONITORING VISIBLE

In Arm 1, participants will undergo URS with real-time IRP monitoring visible to surgeons using the LithoVue Elite™.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Parallel assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Males or females over 18 years of age * Undergoing flexible ureteroscopy to address urinary stones located in the proximal ureter or kidney * Total stone burden over 2 cm

Exclusion criteria

1. Undergoing bilateral stone treatment during the same procedure 2. Patients with known genitourinary anatomical abnormalities 3. Uncorrected coagulopathy 4. Patients with urinary diversions 5. Chronic external urinary catheters 6. Women who are pregnant 7. Immunosuppressed patients

Design outcomes

Primary

MeasureTime frameDescription
Surgeon behavior as measured by mean Non-Technical Skills for Surgeons (NOTSS) score.ProcedureTreating investigators will be evaluated using the modified NOTSS tool during the procedure. The NOTSS is used to measure non-technical skills in the operation room in the following categories; situation awareness, decision making, communication \& teamwork, and leadership.

Secondary

MeasureTime frameDescription
Difference in decision-making domain scores as measured by the Non-Technical Skills for Surgeons (NOTSS) scoresProcedureTreating investigators will be evaluated using the modified NOTSS tool during the procedure. The NOTSS is used to measure non-technical skills in the operation room in the following categories; situation awareness, decision making, communication \& teamwork, and leadership.
Post-operative infection30-days post-operativePatient signs and symptoms concerning for a urinary tract infection, along with a positive urine culture
Perioperative patient outcomes as measured by Clavien-Dindo classification systemUp to 30 daysIntraoperative complications will be categorized based on the Clavien-Dindo classification system
Post-operative pain as measured by Visual analog scale (VAS)Immediately post-operative and up to 7 daysThe VAS is a valid and reliable method for quantifying pain intensity on a scale of 0 to 10, where 0 represents no pain and 10 represents the most severe pain possible.
Post-operative pain as measured by opioid useImmediately post-operative and up to 7 daysOpioid usage will be tracked

Countries

United States

Contacts

CONTACTJane Ledesma
jledesma2@kumc.edu19135888721
PRINCIPAL_INVESTIGATORBristol B Whiles, MD

University of Kansas Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 5, 2026